Advertisements



Nektar announces six abstracts accepted for ASCO

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 16th, 2018

Conatus announces three accepted abstracts for AASLD annual meeting

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 2nd, 2018

Aduro announces four abstracts accepted for presentation at SITC meeting

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 1st, 2018

Nektar announces FDA accepted NDA fro NKTR-181

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 30th, 2018

Tyme Technologies announces five clinical abstracts at ASCO annual meeting

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 17th, 2018

Ovid Therapeutics announces Phase 2 STARS topline data accepted for presentation

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 16th, 2018

Evoke Pharma announces Gimoti NDA accepted for review by FDA

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 16th, 2018

EMD Serono announces NDA resubmission for cladribine tablets accepted by FDA

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 30th, 2018

Unlocked: NBJ announces 2018 Small Business Awards honorees

Their employee count may be small, but they have a big impact on Nashville's business community. The Nashville Business Journal is excited to announce our 2018 Small Business Awards honorees. To assemble our list of winners, we accepted nominations .....»»

Category: topSource: bizjournalsJul 2nd, 2018

Bristol-Myers" BLA for Opdivo Label Expansion Accepted by FDA

Bristol-Myers Squibb Company (BMY) announces that the FDA accepts its suppleme.....»»

Category: worldSource: nytJun 22nd, 2018

Stemline announces "positive" presentations of SL-801, SL-701 at ASCO

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 5th, 2018

Novartis Announces Positive Data on Kisqali and Tasigna

Novartis (NVS) announces positive data on breast cancer drug Kisqali and oncology drug Tasigna at the ASCO. Novartis NVS presented posi.....»»

Category: dealsSource: nytJun 4th, 2018

Pfizer announces OS improvement in dacomitinib compared to gefitinib at ASCO

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 4th, 2018

Agios Pharmaceuticals announces new data from ivosidenib Phase 1 study at ASCO

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 4th, 2018

Technical Take: Nektar plunges after ASCO update

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 4th, 2018

Nektar drops 28%, or $25.45, to $64.90 following ASCO update

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 4th, 2018

Nektar Therapeutics Preliminary Results At ASCO Means A Strong Push Into Phase 3 Studies

Nektar Therapeutics Preliminary Results At ASCO Means A Strong Push Into Phase 3 Studies.....»»

Category: topSource: seekingalphaJun 4th, 2018

Zymeworks announces ZW25 clinical data presented at ASCO

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 1st, 2018

Nektar announces NDA application submission for NKTR-181

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 31st, 2018

Nektar to hold 2018 ASCO Investor Event

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 25th, 2018

Brainstorm Health: FDA Name and Shame, ASCO Abstracts, Non-Opioid Withdrawal Drug

Brainstorm Health Daily: May 17, 2018 Hello, readers! This is Sy. The Food and Drug Administration (FDA) is taking what, for an agency that’s generally known for its caution and under-the-radar regulatory approach, may be seen.....»»

Category: europeSource: fortuneMay 17th, 2018